Spyre Therapeutics, Inc.SYRENASDAQ
Loading
Year-over-year total asset growth rate
5Y CAGR
-21.7%/yr
Long-term compound
Percentile
P50
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 27.82% |
| 2024 | 77.99% |
| 2023 | 380.52% |
| 2022 | -35.28% |
| 2021 | -31.98% |
| 2020 | 94.29% |
| 2019 | 7.00% |
| 2018 | 38.63% |
| 2017 | -16.38% |
| 2016 | 73.50% |